Metabolic quirks yield tumour hope.
Heidi
H
Ledford
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002952:Citric Acid Cycle / Q000235:genetics; D002986:Clinical Trials as Topic; D005947:Glucose / Q000378:metabolism; D005977:Glutarates / Q000378:metabolism; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D053858:Metabolic Networks and Pathways / Q000235:genetics; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D011770:Pyruvate Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D005977:Glutarates; C019417:alpha-hydroxyglutarate; C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human; D011770:Pyruvate Kinase; D005947:Glucose